Why Osteoboost
Science
FAQ
For Clinicians
Login
Shop
What’s new at Osteoboost
Explore our latest press releases—product launches, company milestones, and news about the team behind Osteoboost.
October 21, 2025
New Study Shows Self-Guided Online Exercise Program Significantly Improves Strength and Reduces Fall Risk in Midlife and Older Women
October 21, 2025, REDWOOD CITY, CALIF — A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health...
July 14, 2025
Osteoboost Presents Clinical Trial Data Demonstrating High Adherence and Usability for Osteopenia at ENDO 2025
A 12-month randomized, sham-controlled clinical trial has found that Osteoboost, the first and only FDA-cleared prescription medical device for low...
May 7, 2025
Osteoboost Health Launches FDA-Cleared Prescription Wearable Device for Low Bone Density, Filling Critical Treatment Gap for 60M+ Americans
Osteoboost Health, Inc today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for...
March 3, 2025
Osteoboost Health, Inc. Awarded 6th U.S. Patent for Osteoboost, a Wearable Device for Bone Density Improvement
Osteoboost Health Inc. today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 12,232,993 for...
December 4, 2024
Osteoboost Pre-Orders Open: Breakthrough Medical Device to Treat Low Bone Density Begins Shipping Soon
Bone Health Technologies (BHT), a leading medical technology startup developing innovative non-pharmacological solutions to improve bone health and...
October 24, 2024
Osteoboost Joins AgeTech Collaborative™ from AARP Accelerator Program
One of the biggest challenges of aging is the loss of bone density, which too often leads to osteoporosis and serious fractures that significantly...
July 25, 2024
Bone Health Technologies Acquires Wellen
Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health...
July 2, 2024
Bone Health Technologies Granted Fifth U.S. Patent for Low Bone Density Treatment Osteoboost, Adds Two Key Executives
Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today...
March 4, 2024
Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care
Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the...
January 18, 2024
Bone Health Technologies Announces FDA Clearance of Osteoboost, the First Prescription Medical Device to Treat Low Bone Density
Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first...
December 23, 2023
Bone Health Technologies Awarded New Patent for Wearable Treatment for Osteopenia and Osteoporosis in Post-Menopausal Women
Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, has been granted its fourth patent to further...
October 13, 2023
Bone Health Technologies to Present Clinical Data at ASBMR 2023 from Pivotal Trial of Wearable Treatment for Osteopenia in Post-Menopausal Women
Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, is presenting top-line results from its pivotal...
Next
